“Angle PLC Drops Some Major News: A Healthcare and Pharmaceutical Update You Don’t Want to Miss!”
Angle plc Expects 31% Increase in Revenue for 2024 Guildford, Surrey / Access Newswire / January 23, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is thrilled to share a trading update regarding their full-year 2024 financial…